Back
Outlook Therapeutics Stock Predictions
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Sell
24
OTLK
Outlook Therapeutics
Last Price:
7.52
Seasonality Move:
19.48%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!Outlook Therapeutics Stock Forecast
- Over the next 52 weeks, Outlook Therapeutics has on average historically fallen by 11.8% based on the past 7 years of stock performance.
- Outlook Therapeutics has fallen lower in 6 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 85.71%
-
Is Outlook Therapeutics Stock Undervalued?
The current Outlook Therapeutics [OTLK] share price is $7.54. The Score for OTLK is 24, which is 52% below its historic median score of 50, and infers higher risk than normal. - OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Outlook Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Outlook Therapeutics has on average historically fallen by 11.8% based on the past 7 years of stock performance.
Outlook Therapeutics Stock Rating
Sell
24
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics overpriced?
- Outlook Therapeutics has fallen lower in 6 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 85.71%
Outlook Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
outlooktherapeutics.com
52-Week Data
52-Week High:
40.60
52-Week Low:
4.00
Prediction Charts
Market Cap:
162.75M
Price in USD:
7.54
Volume:
369.42K
Beta:
0.43
Technical Analysis
SMA50:
8.40
SMA100:
8.30
SMA200:
10.39
52-Wk Change:
-67.22%
Stock Predictions
-
Is Outlook Therapeutics stock public?
Yes, Outlook Therapeutics is a publicly traded company. -
What is the Outlook Therapeutics stock quote today?
The Outlook Therapeutics stock price is 7.54 USD today. -
How to buy Outlook Therapeutics stock online?
You can buy Outlook Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-24 | 8.29 | 8.20 | 8.66 | 8.00 |
| Apr-25 | 8.14 | 8.19 | 8.37 | 7.85 |
| Apr-26 | 8.22 | 8.43 | 8.50 | 8.14 |
| Apr-29 | 8.35 | 9.10 | 9.19 | 8.35 |
| Apr-30 | 9.10 | 8.92 | 9.29 | 8.81 |
| May-1 | 8.93 | 8.51 | 9.12 | 8.49 |
| May-2 | 8.60 | 8.50 | 8.61 | 8.27 |
| May-3 | 8.57 | 8.60 | 8.88 | 8.52 |
| May-6 | 8.91 | 8.50 | 8.91 | 8.45 |
| May-7 | 8.61 | 8.20 | 8.76 | 8.17 |
| May-8 | 8.20 | 8.00 | 8.26 | 7.81 |
| May-9 | 8.18 | 7.73 | 8.18 | 7.60 |
| May-10 | 7.75 | 7.58 | 7.83 | 7.53 |
| May-13 | 7.57 | 7.54 | 8.13 | 7.50 |
Outlook Therapeutics Earnings
Outlook Therapeutics Earnings Report: Per Share Outlook Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Outlook Therapeutics Forecast Revenue Growth
Outlook Therapeutics Stock Analysis: Historical quarterly revenues per share for Outlook Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and an increase next year of $1.59 per share.
* Outlook Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.